Bill
S 2315
Bill S 2315 eliminates co-pays for short-term opioid prescriptions, improving access to pain management for patients while reducing financial barriers to necessary medications.
Bill Number: S 2315
Title: Prohibits Co-Pays for Certain Short Term Opioid Drug Prescriptions
Status: Referred to Insurance
Introduced: January 16, 2025
Classification: Bill
Bill S 2315 aims to address the financial barriers that patients face when accessing necessary opioid medications for short-term use. The primary intent of this legislation is to eliminate co-pays for specific opioid prescriptions, thereby improving patient access to pain management options while also aiming to mitigate the risks associated with opioid misuse.
Co-Pay Elimination: The bill specifically prohibits health insurance plans from imposing co-pays on short-term opioid prescriptions. This includes medications prescribed for acute pain management situations, such as post-surgical recovery or injury treatment.
Definition of Short-Term Use: The bill defines "short-term opioid prescriptions" as those intended for use not exceeding a specified duration (not explicitly defined in the provided information but typically ranges from a few days to a couple of weeks).
Insurance Coverage Requirements: Health insurance providers will be required to cover these prescriptions fully without any out-of-pocket costs to the patient, thus ensuring that financial constraints do not hinder access to necessary medications.
Patients: Individuals prescribed short-term opioid medications for pain relief will benefit directly from the elimination of co-pays, making it easier for them to obtain necessary treatments without financial burden.
Healthcare Providers: Physicians and healthcare professionals may find it easier to prescribe opioids for legitimate medical needs, knowing that patients will not face additional costs.
Insurance Companies: Health insurers will need to adjust their policies and coverage plans to comply with the new requirements set forth by this bill.
Current Status: As of January 16, 2025, the bill has been referred to the Insurance Committee for further consideration and discussion.
Related Legislation: This bill is part of a broader legislative context, with several related bills from prior sessions (S 3666, S 279, S 3497, S 790) and a companion bill (A 5157) that may address similar issues regarding opioid prescriptions and insurance coverage.
Bill S 2315 represents a significant step towards improving access to necessary opioid medications for patients in need of short-term pain management. By eliminating co-pays, the legislation seeks to reduce financial barriers and promote responsible prescribing practices in the context of opioid use. The bill's progress through the legislative process will be closely monitored as it moves through the Insurance Committee.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
